Anchiano Therapeutics Ltd Made Headway
Thu 21 May 20 at 05:30 PM
Anchiano Therapeutics Ltd (ANCN:NASDAQ) shot up at $1.18, a gain of 31.1%. On Wed 20 May 20, ANCN:NASDAQ touched a New 2-Week Intraday Low of $0.89. The stock got featured on our News Catalysts scanner on Tue 19 May 20 at 03:45 PM in the 'AGREEMENT' category. From Wed 06 May 20, the stock recorded 50.00% Up Days and 63.64% Green Days
The share price of the company has been moving sideways in recent weeks.
About Anchiano Therapeutics Ltd (ANCN:NASDAQ)
Anchiano Therapeutics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel therapies to treat cancer in areas of unmet need.
Top 10 Gainers:
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 160.28%
- GNRS (GNRS:NASDAQ), 100%
- Surface Oncology, Inc. (SURF:NASDAQ), 53.35%
- Seneca Biopharma, Inc. (SNCA:NASDAQ), 49.69%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 46.19%
- Celsion Corporation (CLSN:NASDAQ), 36.63%
- Aurora Cannabis Inc. (ACB:NYSE), 36.47%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 35.03%
- Nabors Industries Ltd. (NBR:NYSE), 33.36%
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 31.1%